Related Experiment Videos
[Effectiveness of tobramycin in young children with Salmonella infection]
Insights
Tobramycin significantly shortened recovery time for infant salmonellosis compared to ampicillin. This antibiotic effectively cleared the pathogen, restoring neutrophil function without observed side effects.
Area of Science:
- Pediatric Infectious Diseases
- Microbiology
- Immunology
Context:
- Salmonellosis is a common intestinal infection in infants.
- Host immune response plays a crucial role in recovery.
- Antibiotic resistance is a growing concern in treating bacterial infections.
Purpose:
- To compare the efficacy of tobramycin and ampicillin in treating infant salmonellosis.
- To evaluate the impact of treatment on host immune function, specifically neutrophil bactericidal activity.
- To assess the microbiological clearance of Salmonella typhimurium.
Summary:
- A study involving 108 infants with Salmonella typhimurium infection compared ampicillin and tobramycin treatments.
- Infants treated with tobramycin recovered 8 days faster than those treated with ampicillin.
- Tobramycin treatment led to pathogen eradication and normalized neutrophil function within 15 days, with no adverse effects.
Impact:
- Tobramycin demonstrates superior efficacy and safety for infant salmonellosis treatment.
- This finding supports tobramycin as a preferred therapeutic option for this pediatric population.
- Understanding treatment impact on neutrophil function provides insights into host-pathogen dynamics.
Abstract:
The intestinal form of salmonellosis caused by S. typhimurium and the host immunity were studied in 108 infants. 60 infants were treated with ampicillin and the other 48 infants with tobramycin. The recovery period in patients treated with tobramycin was 8 days less as compared to the patients treated with ampicillin After discontinuation of the tobramycin use the pathogen was not detected in the repeated platings. Bactericidal function of neutrophils in these patients returned to normal within 15 days after the beginning of the treatment. Tobramycin was shown to be a highly active antibiotic in the treatment of salmonellosis of infants. No side effects were observed.